Mgpe-9

General Information


DRACP ID  DRACP05437

Peptide Name   Mgpe-9

Sequence  CRRLRHLRHHYRRRWHRFRC

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  Addition of cysteine in Mgpe3 sequence makes Mgpe9

Chiral  L



Physicochemical Information


Formula  C125H198N56O22S2

Absent amino acids  ADEGIKMNPQSTV

Common amino acids  R

Mass  324049

Pl  12.6

Basic residues  13

Acidic residues  0

Hydrophobic residues  4

Net charge  13

Boman Index  -13535

Hydrophobicity  -200.5

Aliphatic Index  39

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  7115

Absorbance 280nm  374.47

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24816284

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2235

DRACP is developed by Dr.Zheng's team.